| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |